Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive Disease Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04654364
What this trial is testing

Lung Cancer Registry

Who this might be right for
Lung CancerNSCLC Stage IVNSCLC, Stage III+2 more
Arbeitsgemeinschaft medikamentoese Tumortherapie 500
Not applicableStudy completedNCT00303914
What this trial is testing

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+4 more
Eastern Cooperative Oncology Group 2,310
Testing effectiveness (Phase 2)Study completedNCT04221529
What this trial is testing

Patients With ES-SCLC and ECOG PS=2 Receiving Atezolizumab-Carboplatin-Etoposide

Who this might be right for
SCLC, Extensive Stage
AIO-Studien-gGmbH 70
Not applicableUnknownNCT04731909
What this trial is testing

Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive StageLung CancerSmall Cell Lung Cancer
Third Military Medical University 80
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Large-scale testing (Phase 3)UnknownNCT00003696
What this trial is testing

Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Commissie Voor Klinisch Toegepast Onderzoek 250
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07349225
What this trial is testing

Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

Who this might be right for
ES-SCLC
The Second Affiliated Hospital of Dalian Medical University 46
Testing effectiveness (Phase 2)Study completedNCT00388960
What this trial is testing

Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Celgene 99
Testing effectiveness (Phase 2)WithdrawnNCT06052423
What this trial is testing

ARTEMIS-007: HS-20093 in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Hansoh BioMedical R&D Company
Testing effectiveness (Phase 2)UnknownNCT05896059
What this trial is testing

Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Zhejiang Cancer Hospital 21
Early research (Phase 1)Temporarily pausedNCT05403723
What this trial is testing

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
University of Maryland, Baltimore 50
Not applicableUnknownNCT04663438
What this trial is testing

Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Peking Union Medical College Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT00084487
What this trial is testing

Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy

Who this might be right for
Extensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Ended earlyNCT05223647
What this trial is testing

Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
Norwegian University of Science and Technology 239
Large-scale testing (Phase 3)Study completedNCT00290953
What this trial is testing

Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide

Who this might be right for
Lung CancerPulmonary NeoplasmsSmall Cell Lung Cancer
Sanofi 432
Not applicableUnknownNCT04985851
What this trial is testing

To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.

Who this might be right for
Extensive-Stage Small-Cell Lung Cancer
Shanghai Chest Hospital 90
Testing effectiveness (Phase 2)Study completedNCT00005646
What this trial is testing

Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 36
Testing effectiveness (Phase 2)UnknownNCT05296603
What this trial is testing

Efficacy and Biomarker Explanation of IBI-322 Plus Lenvatinib on Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Hunan Province Tumor Hospital 83
Not applicableEnded earlyNCT02011087
What this trial is testing

Bioelectrical Impedance Phase Angle in Predicting Treatment Outcome in Patients With Extensive Stage Small Cell Lung Cancer Receiving First-Line Chemotherapy

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Wake Forest University Health Sciences 1
Large-scale testing (Phase 3)Study completedNCT04665856
What this trial is testing

Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Hoffmann-La Roche 123
Next Page